肝硬化无创诊断:定性与定量影像生物标志物
本文综述了基于超声、CT和MRI的定性与定量影像生物标志物用于无创诊断肝硬化的价值,并讨论了评估肝功能和预后的影像特征及该领域的挑战与未来方向。
要点
- 弹性成像技术可定量评估肝硬度,对肝硬化诊断高度准确。
- 超声弹性成像在临床实践中广泛应用,而MR弹性成像可及性较窄。
- 影像组学和深度学习进一步提高了诊断准确性并减少了主观性。
核心结论
- 基于超声、CT和MRI的多种定性与定量影像生物标志物可用于肝硬化无创诊断,其中弹性成像技术对肝硬化诊断高度准确。
研究设计与样本
- 综述类文章,检索范围与纳入文献原文未报告。
关键影像表现/征象
- 定性影像特征易于应用,但诊断敏感度中等。
- 弹性成像技术可定量评估肝硬度,对肝硬化诊断高度准确。
- 肝表面结节、线性与体积测量、细胞外容积分数、肝胆期肝脏强化及扩散加权成像衍生的参数等定量影像特征可提供肝脏形态、灌注和功能信息,从而可能提高诊断效能。
- 影像组学和深度学习的引入进一步提高了诊断准确性并减少了主观性。
- 若干影像特征可能有助于评估肝硬化患者的肝功能和预后。
诊断标准与关键数值
- 肝活检仍是肝硬化诊断的金标准,但为有创检查且易受采样偏倚和观察者变异影响。
- 弹性成像技术可定量评估肝硬度,对肝硬化诊断高度准确;超声弹性成像在临床实践中广泛应用,MR弹性成像可及性较窄。
- 肝表面结节、线性与体积测量、细胞外容积分数、肝胆期肝脏强化及扩散加权成像衍生参数等定量影像特征尚不适用于临床实践,但可提供额外的肝脏形态、灌注和功能信息。
临床应用与阅片要点
- 定性影像特征易于应用,但诊断敏感度中等。
- 弹性成像技术可定量评估肝硬度,对肝硬化诊断高度准确。
- 影像组学和深度学习进一步提高了诊断准确性并减少了主观性。
局限性
- 部分定量影像特征(肝表面结节、线性与体积测量、细胞外容积分数、肝胆期肝脏强化、扩散加权成像衍生参数)尚不适用于临床实践。
- MR弹性成像可及性较窄。
- 定性影像特征诊断敏感度中等。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
A diagnosis of cirrhosis initiates a shift in the management of chronic liver disease and affects the diagnostic workflow and treatment decision of primary liver cancer. Liver biopsy remains the gold standard for cirrhosis diagnosis, but it is invasive and susceptible to sampling bias and observer variability. Various qualitative and quantitative imaging biomarkers based on ultrasound, CT and MRI have been proposed for noninvasive diagnosis of cirrhosis. Qualitative imaging features are easy to apply but have moderate diagnostic sensitivity. Elastography techniques allow quantitative assessment of liver stiffness and are highly accurate for cirrhosis diagnosis. Ultrasound elastography are widely used in clinical practice, while MR elastography has narrower availability. Although not applicable in clinical practice yet, other quantitative imaging features, including liver surface nodularity, linear and volumetric measurement, extracellular volume fraction, liver enhancement on hepatobiliary phase, and parameters derived from diffusion-weighted imaging, can provide additional information of liver morphology, perfusion, and function, thus may increase diagnosis performance. The introduction of radiomics and deep learning has further improved diagnostic accuracy while reducing subjectivity. Several imaging features may also help to assess liver function and outcomes in patients with cirrhosis. In this review, we summarize the qualitative and quantitative imaging biomarkers for noninvasive cirrhosis diagnosis, and the assessment of liver function and outcomes, and discuss the challenges and future directions in this field.
引用
- Zheng T, Qu Y, Chen J, et al. Noninvasive diagnosis of liver cirrhosis: qualitative and quantitative imaging biomarkers. Abdom Radiol (NY). 2024. PMID: 38372765. doi:10.1007/s00261-024-04225-8
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。